In the fourth part of his Pharma Commerce video interview, Mark Lee, MarqVision’s founder and CEO, discusses how healthcare ...

HC Wainwright backs Achieve Life Sciences with a Buy rating as cytisinicline nears potential 2026 FDA approval, targeting a ...

Padcev-Keytruda will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.

Since COVID, there've been growing initiatives in Africa to start producing vaccines and medicines locally, thus gaining greater independence from global supply chains. But are these schemes ...

Pfizer stock currently trades at very low volatility. That could mean it’s ripe for a breakout trade, like a long strangle.

While phase 1 data suggest the novel vaccine can boost immunity and reduce relapse in pancreatic and colorectal cancer, experts remain cautious at this initial stage.

Reimbursement authority NICE has backed the use of the two drugs as a first-line option for patients living with urothelial cancer (UC) – the most common form of bladder cancer – which has spread to ...

In separate multidistrict litigation dockets over injectible birth control Depo-Provera and toxic chemicals in drinking water, federal judges ordered plaintiffs’ lawyers to file their lawsuits after ...

Pfizer Inc. (NYSE:PFE) discovers, develops, markets, and sells biopharmaceutical products in the U.S. and internationally. It ...

Inspired by the success of human weight-loss drugs, scientists are exploring similar solutions for obese dogs. Vivani Medical and Okava are testing \"O ...

“Prior to the EV-302 clinical trial, the treatment of advanced bladder cancer treatment hadn’t significantly changed since the 1980s,” Professor Thomas Powles, director of Barts Cancer Institute ...

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...